BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 36982825)

  • 1. A View on Uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity.
    Koltsova AS; Efimova OA; Pendina AA
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma.
    Berta DG; Kuisma H; Välimäki N; Räisänen M; Jäntti M; Pasanen A; Karhu A; Kaukomaa J; Taira A; Cajuso T; Nieminen S; Penttinen RM; Ahonen S; Lehtonen R; Mehine M; Vahteristo P; Jalkanen J; Sahu B; Ravantti J; Mäkinen N; Rajamäki K; Palin K; Taipale J; Heikinheimo O; Bützow R; Kaasinen E; Aaltonen LA
    Nature; 2021 Aug; 596(7872):398-403. PubMed ID: 34349258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients.
    Osinovskaya NS; Malysheva OV; Shved NY; Ivashchenko TE; Sultanov IY; Efimova OA; Yarmolinskaya MI; Bezhenar VF; Baranov VS
    Int J Gynecol Pathol; 2016 Nov; 35(6):509-515. PubMed ID: 26630226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma.
    Mello JBH; Barros-Filho MC; Abreu FB; Cirilo PDR; Domingues MAC; Pontes A; Rogatto SR
    Mol Hum Reprod; 2018 Nov; 24(11):556-563. PubMed ID: 30376129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix, and vesicles.
    Carbajo-García MC; Corachán A; Juárez-Barber E; Monleón J; Payá V; Trelis A; Quiñonero A; Pellicer A; Ferrero H
    J Pathol; 2022 Aug; 257(5):663-673. PubMed ID: 35472162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma.
    Di Tommaso S; Tinelli A; Malvasi A; Massari S
    Mol Hum Reprod; 2014 Oct; 20(10):1009-15. PubMed ID: 25015674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cultures in uterine leiomyomas: rapid disappearance of cells carrying MED12 mutations.
    Nadine Markowski D; Tadayyon M; Bartnitzke S; Belge G; Maria Helmke B; Bullerdiek J
    Genes Chromosomes Cancer; 2014 Apr; 53(4):317-23. PubMed ID: 24446130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.
    Bertsch E; Qiang W; Zhang Q; Espona-Fiedler M; Druschitz S; Liu Y; Mittal K; Kong B; Kurita T; Wei JJ
    Mod Pathol; 2014 Aug; 27(8):1144-53. PubMed ID: 24390224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth.
    Bloch J; Holzmann C; Koczan D; Helmke BM; Bullerdiek J
    Oncotarget; 2017 May; 8(21):34762-34772. PubMed ID: 28410233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative systems genetics view of endometriosis and uterine leiomyoma: Two sides of the same coin?
    Baranov VS; Ivaschenko TE; Yarmolinskaya MI
    Syst Biol Reprod Med; 2016; 62(2):93-105. PubMed ID: 26828864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.
    Markowski DN; von Ahsen I; Nezhad MH; Wosniok W; Helmke BM; Bullerdiek J
    Genes Chromosomes Cancer; 2010 Aug; 49(8):661-8. PubMed ID: 20544840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics of uterine leiomyomas: insights from high-throughput sequencing.
    Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P
    Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas.
    Välimäki N; Jokinen V; Cajuso T; Kuisma H; Taira A; Dagnaud O; Ilves S; Kaukomaa J; Pasanen A; Palin K; Heikinheimo O; Bützow R; Aaltonen LA; Karhu A
    Am J Hum Genet; 2023 Mar; 110(3):460-474. PubMed ID: 36773604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3'RNA and whole-genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1.
    Jokinen V; Mehine M; Reinikka S; Khamaiseh S; Ahvenainen T; Äyräväinen A; Härkki P; Bützow R; Pasanen A; Vahteristo P
    Genes Chromosomes Cancer; 2023 Jan; 62(1):27-38. PubMed ID: 35822448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.
    Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA
    Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Cellular Insights into the Development of Uterine Fibroids.
    Machado-Lopez A; Simón C; Mas A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase Val158Met polymorphism is associated with increased risk of multiple uterine leiomyomas either positive or negative for
    Dzhemlikhanova LK; Efimova OA; Osinovskaya NS; Parfenyev SE; Niauri DA; Sultanov IY; Malysheva OV; Pendina AA; Shved NY; Ivashchenko TE; Yarmolinskaya MI; Kakhiani MI; Gorovaya EA; Tkachenko AN; Baranov VS
    J Clin Pathol; 2017 Mar; 70(3):233-236. PubMed ID: 27491313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
    Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
    Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
    Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
    Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MED12 mutation frequency in unselected sporadic uterine leiomyomas.
    Heinonen HR; Sarvilinna NS; Sjöberg J; Kämpjärvi K; Pitkänen E; Vahteristo P; Mäkinen N; Aaltonen LA
    Fertil Steril; 2014 Oct; 102(4):1137-42. PubMed ID: 25108465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.